Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov .
Updates regarding government operating status and resumption of normal operations can be found at OPM.gov .

Dr. Maureen Shuh

Dr. Maureen Shuh

Scientific Review Officer



Biography

Division:
Division of Translational and Clinical Sciences DTCS
Review Branch:
Cancer Therapeutics CTH
Study Section:
Advancing Therapeutics A ATA

Dr. Maureen Shuh received her Ph.D. at Brown University in biochemistry, molecular biology, and cell biology, and completed her post-doctoral fellowship in molecular retrovirology at the National Cancer Institute (NCI) at Frederick. After NCI, she was an assistant and associate professor at Loyola University New Orleans and then joined the College of Pharmacy at Xavier University of Louisiana as an Associate Professor. Prior to joining CSR, she was a professor at Hackensack Meridian School of Medicine. Dr. Shuh’s research was focused on the molecular mechanisms of T cell transformation by the human T cell lymphotrophic virus type I (HTLV-1) in adult T cell leukemia (ATL).

 

Last updated: 08/21/2025 05:05